The aberrant splicing of CDKN3 (cyclin-dependent kinase inhibitor 3) mRNA in human gliomas generated a dominant negative CDKN3 variant and the CDKN3 over expression correlated with decreased patient survival [31]. This evidence concerns the gene CDKN3 and glioma.